Clinical Trials

After just three days taking a few tiny drops of a medicinal cannabis oil product, Danny Battershill says his life has changed. The 29-year-old Rodney resident has gained medical approval to trial a legally imported Canadian product, after proving that other medications for his chronic eczema no longer work. He says treatments such as steroids, […]

by

In June, for the first time, The Food and Drug Administration  approved a plant-derived medicine from marijuana. The prescription drug, known as Epidiolex, contains a proprietary formulation of cannabis’ organic compounds — primarily cannabidiol (CBD) —for the treatment of severe seizure disorders. The British pharmaceutical company — the manufacturer of the drug — a has […]

by

CBD can be taken in a few ways. Oil is probably the most popular, but it can also be taken in capsule form, or even as a chocolate or gummy. After a week of taking CBD in oil form every night, it was clear I’d stumbled across something kind of remarkable. I often slept well […]

by

Posted: Tuesday, September 11, 2018 7:01 am Tilray® Exports 2:100 CBD Oil to the United Kingdom Associated Press | NANAIMO, British Columbia–(BUSINESS WIRE)–Sep 11, 2018–Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed,… read more at: https://www.oaoa.com/news/business/article_f19de45a-645c-55e9-ad8c-262f731706ee.html

by

Tilray announced the successful import of its Tilray 2:100 product into the United Kingdom. Tilray (NASDAQ:TLRY) announced the successful import of its Tilray 2:100 cannabidiol (CBD) oil product into the UK to supply a pediatric patient. As quoted in the press release: The changing regulatory measures in the United Kingdom (UK) previously prohibited the use of medical cannabis. However, […]

by

NANAIMO, British Columbia — Tilray Inc. (NASDAQ:TLRY), a global leader in cannabis research, production and distribution, announced today that Tilray 2:100, a product produced at Tilray’s federally licensed, Good Manufacturing Practice (GMP)-certified facility in Canada, was successfully imported into the United Kingdom, to supply a pediatric patient in need. The changing regulatory measures in the […]

by

No media source currently available Pop-out player British scientists have found how a substance in the cannabis plant acts in the brain to reduce abnormal activity in patients at risk of psychosis. Their findings suggest that the substance could be used in a possible treatment for the condition. Cannabis, also known as marijuana, is illegal […]

by

GW Pharmaceuticals has presented positive data on the safety and effectiveness of Epidiolex, recently approved by the U.S. Food and Drug Administration (FDA) to treat epileptic seizures in Dravet and Lennox-Gastaut syndromes, as well as the potential mechanisms behind its anti-epileptic properties. The data were presented at the 13th Annual European Congress of Epileptology (ECE), held recently in Vienna, Austria. GW […]

by

The psychiatric research journal, JAMA Psychiatry, has just published a new CBD study. The study suggests that CDB could have positive antipsychotic effects on individuals with high-risk clinical psychosis. JAMA Psychiatry This study builds off compelling prior research that has demonstrated CBD’s therapeutic effects. Not only does the new study shed important light on whether […]

by

A new study has suggested cannabis extract could be used to treat psychosis, despite long-held views that recreational use of cannabis itself could be linked to developing psychosis. Researchers from King’s College London found cannabidiol (CBD), one of the major chemical components of the marijuana plant, works separately to THC (tetrahydrocannabinol), which the part that gives users a […]

by

The psychiatric research journal, JAMA Psychiatry, has just published a new CBD study. The study suggests that CDB could have positive antipsychotic effects on individuals with high-risk clinical psychosis. JAMA Psychiatry This study builds off compelling prior research that has demonstrated CBD’s therapeutic effects. Not only does the new study shed important light on whether […]

by

Following doctor’s orders, Brian and Damaris Higuera drove home to let their baby die. Not quite nine months old, Sadie had already endured a lifetime of medical treatments. Due to a rare genetic disorder, Schnizel Giedeon Syndrome, one of her kidneys malfunctioned, her intestines were displaced and her brain lacked the nerve fibers linking the […]

by